NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

This Week on NeurologyLive® — June 30, 2025

This Week on NeurologyLive® — June 30, 2025

NeurologyLive® Staff
June 30th 2025

Here's some of what is coming soon to NeurologyLive® this week.

Eptinezumab Improves Medication Overuse Headache, Submission for GTx-104 in Subarachnoid Hemorrhage, FDA Expands Indication for Vizamyl PET Imaging

Eptinezumab Improves Medication Overuse Headache, Submission for GTx-104 in Subarachnoid Hemorrhage, FDA Expands Indication for Vizamyl PET Imaging

NeurologyLive® Staff
Published: June 28th 2025 | Updated: June 28th 2025

Neurology News Network. for the week ending June 28, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — June 27, 2025

NeurologyLive® Friday 5 — June 27, 2025

NeurologyLive® Staff
June 27th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 27, 2025.

This Week on NeurologyLive® — June 23, 2025

This Week on NeurologyLive® — June 23, 2025

NeurologyLive® Staff
June 23rd 2025

Here's some of what is coming soon to NeurologyLive® this week.

Atogepant Outperforms Topiramate, IND Accepted for ORX142, Prasinezumab Heads to Phase 3 Parkinson Disease Studies

Atogepant Outperforms Topiramate, IND Accepted for ORX142, Prasinezumab Heads to Phase 3 Parkinson Disease Studies

NeurologyLive® Staff
Published: June 21st 2025 | Updated: June 21st 2025

Neurology News Network. for the week ending June 21, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — June 20, 2025

NeurologyLive® Friday 5 — June 20, 2025

NeurologyLive® Staff
June 20th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 20, 2025.

Understanding How a Rare Brain Wasting Disease Hides in Neurons For Decades

Understanding How a Rare Brain Wasting Disease Hides in Neurons For Decades

NeurologyLive® Staff
June 16th 2025

Researchers uncover a latent infection model for Creutzfeldt-Jakob disease, revealing insights into its mysterious origins and potential triggers.

This Week on NeurologyLive® — June 16, 2025

This Week on NeurologyLive® — June 16, 2025

NeurologyLive® Staff
June 16th 2025

Here's some of what is coming soon to NeurologyLive® this week.

Once-Nightly Oxybate Reduces Sleep-Related Eating, Samelisant Improves Excessive Daytime Sleepiness, Tirzepatide's Impact on OSA and Obesity

Once-Nightly Oxybate Reduces Sleep-Related Eating, Samelisant Improves Excessive Daytime Sleepiness, Tirzepatide's Impact on OSA and Obesity

NeurologyLive® Staff
Published: June 14th 2025 | Updated: June 14th 2025

Neurology News Network. for the week ending June 14, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — June 13, 2025

NeurologyLive® Friday 5 — June 13, 2025

NeurologyLive® Staff
June 13th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 13, 2025.

This Week on NeurologyLive® — June 9, 2025

This Week on NeurologyLive® — June 9, 2025

NeurologyLive® Staff
June 9th 2025

Here's some of what is coming soon to NeurologyLive® this week.

RGX-202 Shows Continued Promise in DMD, AJ201 Meets End Points in Spinal and Bulbar Muscular Atrophy, Ponesimod Effect Sustained Over Long-Term

RGX-202 Shows Continued Promise in DMD, AJ201 Meets End Points in Spinal and Bulbar Muscular Atrophy, Ponesimod Effect Sustained Over Long-Term

NeurologyLive® Staff
Published: June 7th 2025 | Updated: June 7th 2025

Neurology News Network. for the week ending June 7, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — June 6, 2025

NeurologyLive® Friday 5 — June 6, 2025

NeurologyLive® Staff
June 6th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 6, 2025.

This Week on NeurologyLive® — June 2, 2025

This Week on NeurologyLive® — June 2, 2025

NeurologyLive® Staff
June 2nd 2025

Here's some of what is coming soon to NeurologyLive® this week.

ADDRESS-LC Study of Long COVID Initiated, Phase 4 Trial Testing IVIg Transition to Efgartigimod, Lack of Rebound Effect Seen in Ozanimod

ADDRESS-LC Study of Long COVID Initiated, Phase 4 Trial Testing IVIg Transition to Efgartigimod, Lack of Rebound Effect Seen in Ozanimod

NeurologyLive® Staff
Published: May 31st 2025 | Updated: May 31st 2025

Neurology News Network. for the week ending May 31, 2025. [WATCH TIME: 4 minutes]

CMSC Live: 2025 Annual Meeting Day 3

CMSC Live: 2025 Annual Meeting Day 3

NeurologyLive® Staff;Jeffrey Wilken, PhD;Riley Bove, MD
May 31st 2025

Host Jeffrey Wilken, PhD, chats with Riley Bove, MD, about the third day of the 2025 CMSC Annual Meeting in Phoenix, Arizona.

NeurologyLive® Friday 5 — May 30, 2025

NeurologyLive® Friday 5 — May 30, 2025

NeurologyLive® Staff
May 30th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 30, 2025.

Neuroscience at AHN Saint Vincent: Advanced Treatments and Collaborative Care Closer to Home

Neuroscience at AHN Saint Vincent: Advanced Treatments and Collaborative Care Closer to Home

NeurologyLive® Staff
May 30th 2025

AHN Saint Vincent Hospital offers advanced neurological care, reducing wait times and providing local access to specialized treatments for various conditions.

CMSC Live: 2025 Annual Meeting Day 2

CMSC Live: 2025 Annual Meeting Day 2

NeurologyLive® Staff;Jeffrey Wilken, PhD;Anthony Feinstein, MPhil, PhD, FRCP
May 30th 2025

Host Jeffrey Wilken, PhD, chats with Anthony Feinstein, MPhil, PhD, FRCP, about the second day of the 2025 CMSC Annual Meeting in Phoenix, Arizona.

CMSC Live: 2025 Annual Meeting Day 1

CMSC Live: 2025 Annual Meeting Day 1

NeurologyLive® Staff;Jeffrey Wilken, PhD;Marie Namey, APRN, MSCN
May 29th 2025

Host Jeffrey Wilken, PhD, chats with Marie Namey, APRN, MSCN, about the first day of the 2025 CMSC Annual Meeting in Phoenix, Arizona.

Abstracts for the 2025 CMSC Annual Meeting Are Now Live!

Abstracts for the 2025 CMSC Annual Meeting Are Now Live!

NeurologyLive® Staff
May 27th 2025

The 39th CMSC Annual Meeting is set to be held May 28-31, 2025, in Phoenix, Arizona. The International Journal of MS Care has published the abstracts.

This Week on NeurologyLive® — May 26, 2025

This Week on NeurologyLive® — May 26, 2025

NeurologyLive® Staff
May 26th 2025

Here's some of what is coming soon to NeurologyLive® this week.

Positive Phase 3 Data for Oral OSA Medication AD109, FDA Clears First Blood Test for Alzheimer Disease, DHE Autoinjector Treatment Approved for Migraine

Positive Phase 3 Data for Oral OSA Medication AD109, FDA Clears First Blood Test for Alzheimer Disease, DHE Autoinjector Treatment Approved for Migraine

NeurologyLive® Staff
Published: May 24th 2025 | Updated: May 24th 2025

Neurology News Network. for the week ending May 24, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — May 23, 2025

NeurologyLive® Friday 5 — May 23, 2025

NeurologyLive® Staff
May 23rd 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 23, 2025.

This Week on NeurologyLive® — May 19, 2025

This Week on NeurologyLive® — May 19, 2025

NeurologyLive® Staff
May 19th 2025

Here's some of what is coming soon to NeurologyLive® this week.

AMX0035 Continues Promise in Wolfram Syndrome, FDA Clears Testing for CAP-002, Gene Therapy AAV-GAD Gains RMAT Designation

AMX0035 Continues Promise in Wolfram Syndrome, FDA Clears Testing for CAP-002, Gene Therapy AAV-GAD Gains RMAT Designation

NeurologyLive® Staff
Published: May 17th 2025 | Updated: May 17th 2025

Neurology News Network. for the week ending May 10, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — May 16, 2025

NeurologyLive® Friday 5 — May 16, 2025

NeurologyLive® Staff
May 16th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 16, 2025.

This Week on NeurologyLive® — May 12, 2025

This Week on NeurologyLive® — May 12, 2025

NeurologyLive® Staff
May 12th 2025

Here's some of what is coming soon to NeurologyLive® this week.

EAP Program Authorized for ALS Agent SPG302, PTC518 Meets Primary End Point, Capricor Completes Mid-Cycle Review for Deramiocel

EAP Program Authorized for ALS Agent SPG302, PTC518 Meets Primary End Point, Capricor Completes Mid-Cycle Review for Deramiocel

NeurologyLive® Staff
Published: May 10th 2025 | Updated: May 10th 2025

Neurology News Network. for the week ending May 10, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — May 9, 2025

NeurologyLive® Friday 5 — May 9, 2025

NeurologyLive® Staff
May 9th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 9, 2025.

12345678
...
37>

Latest Updated Articles

Jannis Müller, MD, MSc (Credit: LinkedIn)
Published: May 14th 2025 | Updated: May 16th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)
Published: May 12th 2025 | Updated: May 13th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
Published: February 15th 2025 | Updated: February 18th 2025
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
© 2025 MJH Life Sciences

All rights reserved.